It is a business services private limited company based in Nagpur, Maharashtra, India, established in 2016.
2016 | Nagpur, Maharashtra, India | ActiveEpicare Pharma Private Limited, a active private limited company, was established on 17 October 2016 in Nagpur, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999MH2016PTC286832. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Pramod Nehalsingh Bisen (Director), Swapnil Ramkishor Jaiswal (Director). Past directors included Shamsunder Suryakant Jagdale, Niranjan Vijayrao Deshmukh, Swapnil Ramkishor Jaiswal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H No.6635/A P No.173 Aradhana Nagar, Nagpur, Maharashtra, 440027.
U74999MH2016PTC286832
286832
17 October 2016
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Epicare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramod Nehalsingh Bisen | Director | 17 Oct 2016 | Current |
| Swapnil Ramkishor Jaiswal | Director | 01 Jun 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Mar 2019 | Past |
| Pramod Abcsdd | Director | 01 Jan 2017 | Past |
| Pramod Abcsdd | Director | 01 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epicare Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Epicare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Epicare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Epicare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epicare Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Epicare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Epicare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Swapnil Ramkishor Jaiswal was appointed as a Director was appointed as a Director on 01 Jun 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
Pramod Nehalsingh Bisen was appointed as a Director was appointed as a Director on 17 Oct 2016 & has been associated with this company since 9 years 2 months . was recorded as a recent event.
Progress on Epicare Pharma Private Limited was registered on 17 Oct 2016 with Roc Mumbai & aged 9 years 2 months as per MCA records. was documented.
The CIN of Epicare Pharma Private Limited is U74999MH2016PTC286832.
Epicare Pharma Private Limited is headquartered at H No.6635/A P No.173 Aradhana Nagar, Nagpur, Maharashtra, 440027.
Epicare Pharma Private Limited was incorporated on 17 October 2016.
The current directors of Epicare Pharma Private Limited are
The primary industry of Epicare Pharma Private Limited is Business Services.
Epicare Pharma Private Limited is unlisted.
The authorized capital of Epicare Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Epicare Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX